KDM6B is upregulated via Smad signaling by activated by transforming growth factor-β (TGF-β), and that KDM6B in turn upregulates SNAI1, which is a master transcription factor in epithelial-mesenchymal transition (EMT) and cancer progression (Figure 3) (40, 41). This evidence concerns the gene KDM6B and cancer.